SCI
10April
TislelizumabPlusChemotherapyvsChemotherapyAloneasFirst-lineTreatmentforAdvancedSquamousNon–Small-CellLungCancerAPhase3RandomizedClinicalTrial(JAMAOncol,IF:24.)
WangJie,LuShun,YuXinminetal.TislelizumabPlusChemotherapyvsChemotherapyAloneasFirst-lineTreatmentforAdvancedSquamousNon-Small-CellLungCancer:APhase3RandomizedClinicalTrial.[J].JAMAOncol,,undefined:undefined.
Importance重要性Thisstudydemonstratesthattislelizumabin
